Etoricoxib

Therapeutic indications

Etoricoxib is indicated for:

Ankylosing spondylitis

Population group: only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Osteoarthritis

Population group: only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute gouty arthritis

Population group: only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute pain conditions

Population group: only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Rheumatoid arthritis

Population group: only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Postoperative dental surgery pain

Population group: only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Etoricoxib is contraindicated in the following cases:

Pregnancy

Lactation

Active peptic ulceration

Active gastro-intestinal (GI) bleeding

Severe hepatic dysfunction (serum albumin <25 g/l or Child-Pugh score ≥10)

Estimated renal creatinine clearance <30 ml/min

Inflammatory bowel disease

Congestive heart failure (NYHA II-IV)

Hypertension

Ischemic heart disease

Peripheral arterial occlusive disease

Cerebrovascular disease